Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amir Kaki, MD
Ascension St. John Hospital
Principal Investigator - Navin Kapur, MD
Abiomed Inc.
Study Director - Seth Bilazarian, MD
Abiomed Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph'S Medical Center - Phoenix
Phoenix, Arizona, United States
- Pima Heart & Vascular
Tucson, Arizona, United States
- Arkansas Heart Hospital
Little Rock, Arkansas, United States
- Adventist Health Glendale
Glendale, California, United States
- Keck Hospital of Usc
Los Angeles, California, United States
- Loma Linda University Medical Center
San Bernardino, California, United States
- Manatee Memorial Hospital
Bradenton, Florida, United States
- North Florida Regional Medical Center
Gainesville, Florida, United States
- Adventhealth - Tampa
Tampa, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Ochsner Foundation Hospital
New Orleans, Louisiana, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Ascension St. John Hospital
Detroit, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Spectrum Health
Grand Rapids, Michigan, United States
- St. Cloud (centracare)
Saint Cloud, Minnesota, United States
- Providence St. Patrick
Missoula, Montana, United States
- Hackensack University Medical Ctr
Hackensack, New Jersey, United States
- Morristown Medical Center
Morristown, New Jersey, United States
- the Valley Hospital
Ridgewood, New Jersey, United States
- New Mexico Heart Institute
Albuquerque, New Mexico, United States
- Buffalo General
Buffalo, New York, United States
- Cumc/ New York Presbyterian Hospital
New York, New York, United States
- Lenox Hill Hospital
New York, New York, United States
- Oklahoma Heart Hospital - South
Oklahoma City, Oklahoma, United States
- Providence St. Vincent Med Center
Portland, Oregon, United States
- Tristar Centennial Medical Center
Nashville, Tennessee, United States
- Texas Health Presbyterian Hospital Dallas
Dallas, Texas, United States
- Baylor Scott & White the Heart Hospital Plano
Plano, Texas, United States
- Methodist Hospital - San Antonio
San Antonio, Texas, United States
- Sentara Norfolk Health System
Norfolk, Virginia, United States
- West Virginia University Hospital
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2022
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 5 Mar 2026
- Registered enrollment
- 856
- Registry id
- NCT05334784
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.